Skip to main content
Tarik Tihan, MD, Pathology, San Francisco, CA, UCSF Medical Center

TarikTihanMD

Pathology San Francisco, CA

Blood Banking & Transfusion Medicine, Neuropathology, Anatomic Pathology

Professor, Pathology, UCSF School of Medicine

Are you Dr. Tihan?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 35 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Tarik Tihan, MD is a board certified pathologist in San Francisco, California. He is currently licensed to practice medicine in California, Pennsylvania, and Maryland. He is affiliated with UCSF Medical Center, Kaiser Permanente San Francisco Medical Center, and Zuckerberg San Francisco General Hospital and Trauma Center.

Education & Training

  • Stony Brook Medicine
    Stony Brook MedicineFellowship, Neuropathology, 1995 - 1997
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Blood Banking/Transfusion Medicine, 1994 - 1995
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1994
  • Istanbul University Fom
    Istanbul University FomClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • NY State Medical License
    NY State Medical License 1995 - 2013
  • MD State Medical License
    MD State Medical License 1997 - 2011
  • PA State Medical License
    PA State Medical License 2008 - 2008
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Neuropathology

Publications & Presentations

PubMed

Press Mentions

  • For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted Treatments
    For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted TreatmentsNovember 16th, 2016

Hospital Affiliations